Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $15.78M | $1.71M | +822.75% |
Operating Income | $-152.25M | $-204.56M | +25.57% |
Net Income | $-154.44M | $-191.7M | +19.44% |
EPS (Basic) | $-1.80 | $-2.33 | +22.75% |
EPS (Diluted) | $-1.80 | $-2.33 | +22.75% |
R&D Expense | $62.55M | $150.64M | -58.48% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $201.75M | $327.57M | -38.41% |
Current Assets | $176.89M | $271.14M | -34.76% |
Total Liabilities | $188.3M | $151.93M | +23.93% |
Current Liabilities | $61.77M | $72.35M | -14.62% |
Stockholders' Equity | $13.45M | $175.63M | -92.34% |
Cash & Equivalents | $165.65M | $95.83M | +72.85% |
Long-Term Debt | $54.07M | — | — |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $-128.85M | $-159.52M | +19.22% |
Investing Cash Flow | $138.61M | $131.19M | +5.66% |
Financing Cash Flow | $23.14M | $514,000 | +4402.72% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -964.9% | -11962.5% | +10997.59% |
Net Margin | -978.8% | — | — |
ROE | -1148.0% | — | — |
ROA | -76.5% | — | — |
Current Ratio | $2.864 | — | — |
Debt to Equity | $13.997 | — | — |
Other companies in Biotechnology